BRPI0507887A - comprimido de múltiplas camadas - Google Patents
comprimido de múltiplas camadasInfo
- Publication number
- BRPI0507887A BRPI0507887A BRPI0507887-3A BRPI0507887A BRPI0507887A BR PI0507887 A BRPI0507887 A BR PI0507887A BR PI0507887 A BRPI0507887 A BR PI0507887A BR PI0507887 A BRPI0507887 A BR PI0507887A
- Authority
- BR
- Brazil
- Prior art keywords
- tablet
- angiotensin
- instant release
- layer
- multilayer tablet
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B30—PRESSES
- B30B—PRESSES IN GENERAL
- B30B11/00—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses
- B30B11/02—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space
- B30B11/08—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space co-operating with moulds carried by a turntable
- B30B11/085—Presses specially adapted for forming shaped articles from material in particulate or plastic state, e.g. briquetting presses, tabletting presses using a ram exerting pressure on the material in a moulding space co-operating with moulds carried by a turntable for multi-layer articles
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Mechanical Engineering (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Obesity (AREA)
- Endocrinology (AREA)
- Psychiatry (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
COMPRIMIDO DE MúLTIPLAS CAMADAS. A presente invenção refere-se a um comprimido de múltiplas camadas compreende uma primeira camada formulada para liberação instantânea do antagonista de receptor de angiotensina II telmisartan a partir de uma comprimido matricial dissolvente, uma segunda camada formulada para liberação instantânea do inibidor da enzima de conversão de angiotensina ramipril e opcionalmente um diurético de uma comprimido matricial de desintegração, e opcionalmente, uma terceira camada formulada para liberação instantânea de um diurético como hidroclorotiazida a partir de uma comprimido matricial de desintegração rápida.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102004008804A DE102004008804A1 (de) | 2004-02-20 | 2004-02-20 | Mehrschichttablette |
PCT/EP2005/001498 WO2005079762A1 (en) | 2004-02-20 | 2005-02-15 | Multilayer tablet |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0507887A true BRPI0507887A (pt) | 2007-08-07 |
Family
ID=34832975
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0507887-3A BRPI0507887A (pt) | 2004-02-20 | 2005-02-15 | comprimido de múltiplas camadas |
Country Status (20)
Country | Link |
---|---|
US (1) | US20050186274A1 (pt) |
EP (1) | EP1718281A1 (pt) |
JP (1) | JP2007523112A (pt) |
KR (1) | KR20060130671A (pt) |
CN (1) | CN1921840A (pt) |
AR (1) | AR047806A1 (pt) |
AU (1) | AU2005215115A1 (pt) |
BR (1) | BRPI0507887A (pt) |
CA (1) | CA2552902A1 (pt) |
DE (1) | DE102004008804A1 (pt) |
EC (1) | ECSP066779A (pt) |
IL (1) | IL177536A0 (pt) |
MX (1) | MXPA06008225A (pt) |
NO (1) | NO20063997L (pt) |
PE (1) | PE20051127A1 (pt) |
RU (1) | RU2006133453A (pt) |
TW (1) | TW200533389A (pt) |
UY (1) | UY28753A1 (pt) |
WO (1) | WO2005079762A1 (pt) |
ZA (1) | ZA200604913B (pt) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080234353A1 (en) * | 2004-03-24 | 2008-09-25 | Reynir Eyjolfsson | Formulations of Ramipril |
GB0518129D0 (en) * | 2005-09-06 | 2005-10-12 | Arrow Int Ltd | Ramipril formulation |
GB2431579A (en) * | 2005-10-28 | 2007-05-02 | Arrow Int Ltd | Ramipril formulations |
US20070098782A1 (en) * | 2005-10-28 | 2007-05-03 | Selamine Limited | Ramipril Formulation |
US8637078B2 (en) * | 2005-11-24 | 2014-01-28 | Boehringer Ingelheim International Gmbh | Bilayer tablet comprising telmisartan and diuretic |
CA2642761A1 (en) * | 2006-02-23 | 2007-08-30 | Iomedix Sleep International Srl | Compositions and methods for the induction and maintenance of quality sleep |
CA2654890C (en) | 2006-06-16 | 2015-10-06 | Lek Pharmaceuticals D.D. | Pharmaceutical composition |
WO2008001184A2 (en) * | 2006-06-26 | 2008-01-03 | Emcure Pharmaceuticals Limited | Solid composition |
EP1908469A1 (en) | 2006-10-06 | 2008-04-09 | Boehringer Ingelheim Vetmedica Gmbh | Angiotensin II receptor antagonist for the treatment of systemic diseases in cats |
US20080103118A1 (en) * | 2006-10-27 | 2008-05-01 | Iomedix Development International Srl | Composition for improving blood cholesterol levels |
GB0624084D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amino acid salts |
GB0624087D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril combination salt |
GB0624090D0 (en) * | 2006-12-01 | 2007-01-10 | Selamine Ltd | Ramipril amine salts |
EP1970053A1 (en) * | 2007-03-14 | 2008-09-17 | Boehringer Ingelheim Pharma GmbH & Co. KG | Pharmaceutical composition |
PL382311A1 (pl) * | 2007-04-27 | 2008-11-10 | Zakłady Farmaceutyczne POLPHARMA Spółka Akcyjna | Kompozycja farmaceutyczna o polepszonej stabilności zawierająca inhibitor acetylocholinoesterazy lub farmaceutycznie dopuszczalną jego sól oraz sposób jej wytwarzania |
US20090060983A1 (en) * | 2007-08-30 | 2009-03-05 | Bunick Frank J | Method And Composition For Making An Orally Disintegrating Dosage Form |
WO2009058950A2 (en) * | 2007-10-30 | 2009-05-07 | Dr. Reddy's Laboratories Ltd. | Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide |
CN101842085B (zh) * | 2007-10-31 | 2013-01-30 | 麦克内尔-Ppc股份有限公司 | 口腔崩解剂型 |
PL2252273T3 (pl) * | 2008-03-19 | 2017-07-31 | Ratiopharm Gmbh | Stała kompozycja farmaceutyczna zawierająca niepeptydowy związek antagonistyczny receptora angiotensyny II i środek moczopędny |
JP5612674B2 (ja) | 2009-05-20 | 2014-10-22 | ベーリンガー インゲルハイム フェトメディカ ゲゼルシャフト ミットベシュレンクテル ハフツング | テルミサルタンを含む経口懸濁液 |
US8858210B2 (en) | 2009-09-24 | 2014-10-14 | Mcneil-Ppc, Inc. | Manufacture of variable density dosage forms utilizing radiofrequency energy |
US20110070301A1 (en) | 2009-09-24 | 2011-03-24 | Luber Joseph R | Orally transformable tablets |
RU2479310C2 (ru) * | 2011-02-09 | 2013-04-20 | Открытое акционерное общество "Химико-фармацевтический комбинат "АКРИХИН" (ОАО "АКРИХИН") | Фармацевтическая композиция для лечения артериальной гипертензии и застойной сердечной недостаточности и способ ее получения |
CN102885789A (zh) * | 2012-04-05 | 2013-01-23 | 常州制药厂有限公司 | 一种治疗高血压的复方制剂的制备方法 |
US9511028B2 (en) | 2012-05-01 | 2016-12-06 | Johnson & Johnson Consumer Inc. | Orally disintegrating tablet |
US9233491B2 (en) | 2012-05-01 | 2016-01-12 | Johnson & Johnson Consumer Inc. | Machine for production of solid dosage forms |
US9445971B2 (en) | 2012-05-01 | 2016-09-20 | Johnson & Johnson Consumer Inc. | Method of manufacturing solid dosage form |
JP6018420B2 (ja) * | 2012-06-05 | 2016-11-02 | ニプロ株式会社 | アンジオテンシンii受容体拮抗薬およびサイアザイド系利尿薬を含む医薬組成物 |
CN106068120B (zh) | 2014-01-10 | 2021-03-23 | 强生消费者公司 | 使用射频和有损耗的包衣粒子制造片剂的方法 |
EP2979691A1 (en) * | 2014-07-30 | 2016-02-03 | Boehringer Ingelheim International GmbH | Oral disintegrating tablet |
MY192606A (en) * | 2015-06-26 | 2022-08-29 | Abbvie Inc | Solid pharmaceutical compositions for treating hcv |
KR20180025317A (ko) * | 2015-07-17 | 2018-03-08 | 애브비 인코포레이티드 | Hcv의 치료를 위한 고형 약제학적 조성물 |
US10828387B2 (en) | 2015-11-12 | 2020-11-10 | St. Teresa Medical, Inc. | Method of sealing a durotomy |
US10493026B2 (en) | 2017-03-20 | 2019-12-03 | Johnson & Johnson Consumer Inc. | Process for making tablet using radiofrequency and lossy coated particles |
WO2019089717A1 (en) | 2017-11-02 | 2019-05-09 | St. Teresa Medical, Inc. | Fibrin sealant products |
WO2020109319A1 (en) | 2018-11-27 | 2020-06-04 | Zaklady Farmaceutyczne Polpharma S.A | Pharmaceutical composition comprising ramipril and indapamide |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
TW483763B (en) * | 1994-09-02 | 2002-04-21 | Astra Ab | Pharmaceutical composition comprising of ramipril and dihydropyridine compound |
DE4446468A1 (de) * | 1994-12-23 | 1996-06-27 | Basf Ag | Verfahren zur Herstellung von umhüllten Tabletten |
US6087386A (en) * | 1996-06-24 | 2000-07-11 | Merck & Co., Inc. | Composition of enalapril and losartan |
WO2000027397A1 (en) * | 1998-11-06 | 2000-05-18 | Glaxo Group Limited | Antihypertensive medicaments containing lacidipine and telmisartan |
EP1671632A1 (en) * | 2000-08-22 | 2006-06-21 | Boehringer Ingelheim Pharma GmbH & Co. KG | Pharmaceutical combination of angiotensin II antagonists and ACE inhibitors |
GB0020691D0 (en) * | 2000-08-22 | 2000-10-11 | Boehringer Ingelheim Pharma | Pharmaceutical combination |
US20030091630A1 (en) * | 2001-10-25 | 2003-05-15 | Jenny Louie-Helm | Formulation of an erodible, gastric retentive oral dosage form using in vitro disintegration test data |
JP2003144528A (ja) * | 2001-11-15 | 2003-05-20 | Fancl Corp | 多層錠及びその製造方法 |
-
2004
- 2004-02-20 DE DE102004008804A patent/DE102004008804A1/de not_active Withdrawn
-
2005
- 2005-02-10 US US11/056,081 patent/US20050186274A1/en not_active Abandoned
- 2005-02-15 BR BRPI0507887-3A patent/BRPI0507887A/pt not_active IP Right Cessation
- 2005-02-15 AU AU2005215115A patent/AU2005215115A1/en not_active Abandoned
- 2005-02-15 RU RU2006133453/15A patent/RU2006133453A/ru not_active Application Discontinuation
- 2005-02-15 JP JP2006553509A patent/JP2007523112A/ja active Pending
- 2005-02-15 CA CA002552902A patent/CA2552902A1/en not_active Abandoned
- 2005-02-15 MX MXPA06008225A patent/MXPA06008225A/es unknown
- 2005-02-15 CN CNA2005800052700A patent/CN1921840A/zh active Pending
- 2005-02-15 EP EP05707394A patent/EP1718281A1/en not_active Withdrawn
- 2005-02-15 KR KR1020067019409A patent/KR20060130671A/ko not_active Application Discontinuation
- 2005-02-15 WO PCT/EP2005/001498 patent/WO2005079762A1/en active Application Filing
- 2005-02-17 UY UY28753A patent/UY28753A1/es not_active Application Discontinuation
- 2005-02-18 TW TW094104757A patent/TW200533389A/zh unknown
- 2005-02-18 AR ARP050100579A patent/AR047806A1/es unknown
- 2005-02-18 PE PE2005000192A patent/PE20051127A1/es not_active Application Discontinuation
-
2006
- 2006-06-14 ZA ZA200604913A patent/ZA200604913B/en unknown
- 2006-08-17 IL IL177536A patent/IL177536A0/en unknown
- 2006-08-21 EC EC2006006779A patent/ECSP066779A/es unknown
- 2006-09-06 NO NO20063997A patent/NO20063997L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2005079762A1 (en) | 2005-09-01 |
AR047806A1 (es) | 2006-02-22 |
RU2006133453A (ru) | 2008-03-27 |
PE20051127A1 (es) | 2006-01-31 |
KR20060130671A (ko) | 2006-12-19 |
CN1921840A (zh) | 2007-02-28 |
ECSP066779A (es) | 2006-12-20 |
NO20063997L (no) | 2006-11-14 |
UY28753A1 (es) | 2005-09-30 |
US20050186274A1 (en) | 2005-08-25 |
DE102004008804A1 (de) | 2005-09-08 |
IL177536A0 (en) | 2006-12-10 |
EP1718281A1 (en) | 2006-11-08 |
CA2552902A1 (en) | 2005-09-01 |
MXPA06008225A (es) | 2006-08-31 |
TW200533389A (en) | 2005-10-16 |
JP2007523112A (ja) | 2007-08-16 |
ZA200604913B (en) | 2007-11-28 |
AU2005215115A1 (en) | 2005-09-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BRPI0507887A (pt) | comprimido de múltiplas camadas | |
BRPI0517809A (pt) | comprimido de camada dupla | |
WO2009058950A3 (en) | Pharmaceutical formulations comprising telmisartan and hydrochlorothiazide | |
EA200700765A1 (ru) | Двуслойная таблетка | |
HRP20040649B1 (en) | Bilayer pharmaceutical tablet comprising telmisartan and a diuretic and preparation thereof | |
PA8849701A1 (es) | Forma de dosificacion farmaceutica que comprende nifedipino o nisoldipino y un antagonista de anglotensina ii y/o un diuretico | |
BR112012024139A2 (pt) | formulações farmacêuticas de camada dupla contendo agonistas e antagonistas de opióide. | |
CR10277A (es) | Pirazolquinolonas como potentes inhibidores de parp | |
PE20121131A1 (es) | Composicion farmaceutica oral solida en comprimido monocapa que comprende irbesartan y besilato de amlodipina | |
CO6311069A2 (es) | Cápsulas que comprenden ácido acetilsalicílico, un inhibidor de la hmg-coa reductasa y un ace inhibidor para la prevención de enfermedades cardiovasculares | |
UY30365A1 (es) | Comprimido bicapa para la prevención de los accidentes cardiovasculares | |
ECSP066727A (es) | Reacciones de acoplamiento útiles en la preparación de derivados de (1h-tetrazol-5-il)-bifenilo | |
CL2007003613A1 (es) | Compuestos nitroderivados, antagonistas del receptor de angiotensina ii; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar hipertension. | |
RU2016126852A (ru) | Комбинированный фармацевтический препарат, содержащий блокатор рецептора ангиотензина-II и ингибитор ГМГ-КоА редуктазы | |
AR043395A1 (es) | Terapia de combinacion para la hipertension utilizando lercanidipina y un bloqueante de los receptores de angiotensina ii | |
PE20090675A1 (es) | Composicion farmaceutica que contie levosimendan y un antagonista receptor de angiotensina ii o un inhibidor eca | |
ECSP045195A (es) | Un comprimido farmacéutico de dos capas que comprende telmisartán y un diurético y la preparación de dicho comprimido | |
ECSP085195A (es) | Un comprimido farmaceutico de dos capas que comprenden telmisartan y un diurético y la preparación de dicho comprimido | |
TH79790A (th) | ยาเม็ดชนิดสองชั้น | |
TH79790B (th) | ยาเม็ดชนิดสองชั้น | |
AR062613A1 (es) | Formulacion de compuestos organicos | |
TR201205029T1 (tr) | Teobromin içeren yavaş salınımlı tablet. | |
TH75315A (th) | เม็ดแบนที่มีหลายชั้น | |
CL2012001689A1 (es) | Formulación en forma de tableta que comprende hidroxipropilcelulosa y un ingrediente activo seleccionado a partir de compuestos derivados de 1h-quinazolina-2,4-diona, antagonistas del receptor ampa; y un proceso para la elaboración de dicha tabletas. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 5A E 6A ANUIDADE(S). |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2099 DE 29/03/2011. |